New clinical risk management tools are needed to prevent COVID-19 deaths, say experts
A new study exposes the dire need for new clinical risk management tools to help hospital healthcare workers prevent the […]
A survey of U.S. multiple sclerosis, or MS, specialist clinicians reveals the COVID-19 pandemic has created major changes in how […] Like most companies, Apple’s plans for 2020 were upended with the rise of COVID-19. After initial hits to its production […] Although frontline health workers tend to be well-connected, they spend significant time fixing technical problems and attending to patient records […] 21 October 2020 — ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi […] According to the American Foundation for Suicide Prevention, suicide is the 10th leading cause of death in the U.S., with […] Scientists at Fred Hutchinson Cancer Research Center believe they’ve found a better of use of mobile technology to help adult […] Results from a randomized clinical trial have shown that a potential new treatment can help control the immune response of […] As part of its COVID-19 response, the U.S. Food and Drug Administration in April launched a nationwide expanded access program to […] Patients taking part in clinical trials do not receive better treatment than other patients. This is the conclusion of a […]Clinical
Pandemic led to profound changes in multiple sclerosis clinical practice
Apple's 2020 in review: COVID-19 pivots, clinical research partnerships and consumer device updates
Frontline workers say they spend more time on EHRs than patient care
ViiV Healthcare Announces Analysis Showing no Antiretroviral Therapy Interruptions Due to COVID-19 Across its Clinical Development Programme for Investigational, Long-Acting Cabotegravir and Rilpivirine
Deep neural networks show promise for predicting future self-harm based on clinical notes
Fred Hutch-led clinical trial shows new smartphone app helps smokers quit
New insights from first clinical trial of potential treatment for motor neurone disease
FDA pushes need for plasma donations, with Mayo Clinic giving registry support
Study: Treatment of patients in clinical trials is no better than average care